Surgery for early lung adenocarcinoma with specific CT findings
Part of Cancer, Lungs & breathing clinical trials.
This study looks at whether people with a very early type of lung cancer can safely have curative surgery when their CT scan shows a ground-glass type spot with certain size and shape measurements. It aims to help doctors choose the right surgery approach based on the scan features and final pathology.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early lung adenocarcinoma that is clinical stage T1N0M0, and the plan is curative (cancer-removing) surgery
- Your CT scan shows exactly one lesion (one spot) described as a ground-glass nodule, with a C/T ratio of 0.5 or less
- Your age is between 18 and 75, inclusive
- You must be willing to sign the informed consent form
- After surgery, the pathology (lab tissue test) must confirm invasive lung adenocarcinoma only (not a different cancer type)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a lung surgery approach (segmentectomy) for people with early, invasive lung cancer that shows “ground-glass” on scans. It aims to see if this less extensive surgery can treat the cancer effectively when the tumor is in a specific size and scan pattern range.
This trial studies if a limited surgery (wedge resection) works well for small lung cancers that appear as ground-glass opacities on CT scans. It aims to remove the tumor while preserving more lung tissue.
This trial is testing a lung-sparing surgery called segmentectomy for people with a certain type of lung cancer nodule. It aims to see if this surgery is a good option for those with solid-dominant nodules that are 2 to 3 cm in size and have not spread to lymph nodes.
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
This trial studies whether adding chemotherapy after surgery helps people with early-stage lung adenocarcinoma that has a micropapillary pattern. It’s testing whether chemotherapy given after complete tumor removal can improve outcomes compared with surgery alone.
Hear when a new Carcinoma, Non-Small-Cell Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.